Titlebook: Cardiorenal Syndrome in Heart Failure; W. H. Wilson Tang,Frederik H. Verbrugge,Wilfried M Book 2020 Springer Nature Switzerland AG 2020 Ca

不感興趣

詞匯表

demote

FEAS

Mechanisms of Cardiorenal Syndrome: From Molecular Pathways to Novel Therapeuticsel therapeutic for CRS and acute kidney injury (AKI). CRRL269 possesses renal enhancing properties with RAAS suppression and less hypotension than native NPs, thus representing a new and innovative drug for renoprotection in HF. The combination of using NP urinary biomarkers and designer NP therapeu

SEMI

apiary

HPA533

A Patient with Abdominal Congestionvenous congestion. Interestingly, strategies that result in a resolution of the increased IAP in ADHF (e.g. paracentesis or ultrafiltration), have been shown to result in an improvement of renal function. This chapter focusses on the role of abdominal congestion in heart failure.

調(diào)整校對

CBC471

LARK

S. Subramanian,J. R. W. Woittiezel therapeutic for CRS and acute kidney injury (AKI). CRRL269 possesses renal enhancing properties with RAAS suppression and less hypotension than native NPs, thus representing a new and innovative drug for renoprotection in HF. The combination of using NP urinary biomarkers and designer NP therapeu